Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FolateScan in Rheumatoid Arthritis and Inflammatory Diseases
NCT00588393Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Sep 2006
- Primary completion
- Dec 2007
- Countries
- 1
01
Overview
A Phase 2 trial of etarfolatide in rheumatoid arthritis (RA), osteoarthritis (OA), multiple sclerosis (MS), Crohn's disease, systemic lupus erythematosus (SLE), sponsored by Mayo Clinic. Started Sep 2006; status: completed.
02
Drugs
etarfolatide
03
Conditions
rheumatoid arthritis (RA)osteoarthritis (OA)multiple sclerosis (MS)Crohn's diseasesystemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT00588393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00588393.